Literature DB >> 24184282

[Hyperandrogenism in women].

Maëliss Peigné1, Anne Villers-Capelle, Geoffroy Robin, Didier Dewailly.   

Abstract

Clinical signs of hyperandrogenism include hirsutism, acne and/or seborrhea, androgenic alopecia, menstrual disorders and at maximum virilization. Hirsutism is defined by the presence of a coarse and pigmented hair in male territory. In the Caucasian populations, a Ferriman Gallwey score ≥ 6 means hirsutism. Polycystic ovary syndrome is the most common cause of hyerandrogenism in women (70 % of cases) but must remain a diagnosis of exclusion. A neoplasm origin is suspected in case of recent onset of hyperandrogenism, which is rapidly progressive and with signs of virilization. The serum level of total testosterone and 17-hydroxyprogesterone and pelvic ultrasonography are the first line tests in case of clinical hyperandrogenism. Combined oral contraceptive pill can be the first line treatment in case of moderate hyperandrogenia, associated, if needed, with a specific acne treatment. Cyproterone acetate is the best-known and most effective antiandrogenic treatment. It decreases the hair density, speed of regrowth and pigmentation. It is indicated in severe hirsutism and must be combined with cosmetic cares.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24184282     DOI: 10.1016/j.lpm.2013.07.016

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  Preventive online and offline health management intervention in polycystic ovary syndrome.

Authors:  Rui Liu; Min Li; Pei Wang; Man Yu; Zheng Wang; Guang-Zhong Zhang
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

2.  Hyperandrogenism-Insulin Resistance-Acanthosis Nigricans Syndrome.

Authors:  A H Dédjan; A Chadli; S El Aziz; A Farouqi
Journal:  Case Rep Endocrinol       Date:  2015-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.